| 9475808 |
Inhibitor compounds of phosphodiesterase type 10A |
Hervé Geneste, Michael Ochse, Berthold Behl, Loic Laplanche, Jurgen Dinges +1 more |
2016-10-25 |
| 9464085 |
Inhibitor compounds of phosphodiesterase type 10A |
Hervé Geneste, Michael Ochse, Clarissa Jakob |
2016-10-11 |
| 9464072 |
Treatment of central nervous system disorders |
R. Scott Bitner, Kaitlin E. Browman, Michael E. Brune, Yixian Long, Jurgen Dinges +17 more |
2016-10-11 |
| 9388180 |
Inhibitor compounds of phosphodiesterase type 10A |
Hervé Geneste, Michael Ochse, Clarissa Jakob, Maricel Torrent |
2016-07-12 |
| 9388141 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +1 more |
2016-07-12 |
| 9388148 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +1 more |
2016-07-12 |
| 9376396 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +2 more |
2016-06-28 |
| 9273068 |
Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A |
Hervé Geneste, Michael Ochse, Sean Colm Turner, Berthold Behl, Loic Laplanche +3 more |
2016-03-01 |
